Nvidia plans to invest in Doctolib, Entalpic, Genesis AI and Pigment, a four-company sweep across healthcare software, materials discovery, robotics and business planning. Financial terms and closing dates weren’t disclosed. Reuters reported that Doctolib and Genesis AI confirmed Nvidia’s involvement; Nvidia’s October 12 announcement described all four as planned investments.
Doctolib builds software for healthcare professionals and patients. Its consultation assistant uses an internally developed medical speech-recognition model to document visits, while other assistants address coding, billing, office administration and document management. For patients, the company is developing an AI companion intended to help them understand their health and navigate care.
Doctolib says the consultation assistant has documented more than 12 million visits. Its patient companion is already used by 400,000 people in France, though availability for everyone isn’t planned until 2027. The company said Nvidia’s minority investment would support recruiting, product improvements and development of its own models. The stake carries no governance rights or board seat, and Doctolib says Nvidia won’t have access to patient data.
Nvidia described the other companies as tackling different workflows. Pigment’s planning platform helps finance, sales, workforce and operations teams forecast performance and model scenarios. Genesis AI is developing foundation models, data-collection systems, simulation infrastructure and hardware for general-purpose robots. Entalpic applies AI to materials engineering at the atomic scale, including surfaces and interfaces used in semiconductor manufacturing and electronics.
Separately, The Next Web reported that Nvidia CEO Jensen Huang said the company would announce $2 billion of European investments within a week. The outlet, citing Bloomberg, said Nvidia had invested $8 billion in Europe during the preceding year. Those figures describe Nvidia’s broader European push, not the undisclosed amounts committed to these four companies. Doctolib says it has worked with Nvidia for more than a year and will draw on its technical expertise as it refines its models.